Table 4 Lenalidomide treatment exposure (safety population)
|  | L (n = 13) | L + R (n = 11) | L + other (n = 34) | Overall (N = 58) |
|---|---|---|---|---|
Lenalidomide treatment duration, weeks | ||||
 Median | 8.4 | 14.0 | 7.0 | 8.4 |
 Range | 0.4 to 30.0 | 0.9 to 37.9 | 1.1 to 77.9 | 0.4 to 77.9 |
Number of lenalidomide cycles | ||||
 Median | 2.0 | 2.0 | 1.0 | 2.0 |
 Range | 1.0 to 7.0 | 1.0 to 9.0 | 0.0 to 11.0 | 0.0 to 11.0 |
Duration of other therapy combined with lenalidomide, weeks | ||||
 Median | NA | 8.3 | 7.2 | 7.4 |
 Range | NA | 0.1 to 35.9 | 0.7 to 77.7 | 0.1 to 77.7 |